The patented Safe-2-Dose™ Integrated Dosing Container is the next generation Infants elixir dispenser providing enhanced medication dosing accuracy and user convenience. The caregiver need only disabl
The Momenta-Dose™ is a injection device designed to administer small volume subcutaneous or intramuscular injections; solely by a user’s applied force and subsequent momentum created.
A user positions the device against the site of injection and applies a downward force until they exceed the calibrated amount of resistance required to initiate the injection. The activated momentum triggers two subsequent tasks; needle penetration to a pre-determined depth and the release of the device’s contents.
The complete procedure occurs within seconds from a user’s single motion and eliminates the need for complex instructions and multiple steps. The device simply and effectively delivers its contents intramuscularly or subcutaneously without the needle ever visible to the user.
The Momenta-Dose™ is industry unique as it does not use any commercial auto-injector technology such as gases, springs or any other stored kinetic energy. The design obviates the need for intricate mechanisms,
allowing the device to be produced extremely inexpensively compared to currently marketed auto-injectors. The overall cost advantages make the device more financially feasible to first time patients and patients wanting to obtain multiple devices for strategic emergency storage.
The Momenta-Dose™ is available in two variations:
- Self contained and pre-loaded
- Compatible with conventional pre-filled syringes
Momenta-Dose™ Pre-Filled Syringe
The Momenta-Dose™ is an ideal apparatus for life-threatening emergency conditions where a rapid, intuitive, accurate injection is crucial. The activation of the device virtually eliminates all user error from hesitation, attempting to abort, or the device not discharging the complete contents into the injection site or at the correct depth.
Not available in all territories.
The Momenta Dose™ is a registered trademark of Asepsis Medical Technologies, LLC., and covered by one or more patents, including;
US Patent 10,625,026, US Patent 11,484,660 and Patents Pending.
Technical Video
Brochure
Latest News
Asepsis Announces The Grant Of Mexico Patent No. 384,129
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-
Asepsis Announces the Grant of Canadian Patent No. 3,006,218
Asepsis Medical Technologies® is proud to announce their latest Canadian Patent Grant 3,006,218 of August 24, 2021 – for the multi-dose oral Dose-2-Weight Syringe®. The Dose-2-Weight Sy
Asepsis announces the US Patent Grant 11,058,606
Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 11,058,606 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion contai
Asepsis Announces the Grant of Mexico Patent MX/a/2017/012034
The Safe-T-Syringe® is designed to deliver the highest standard of patient care via syringe. Its medication calibrated indicia provide enhanced accuracy, convenience and safety through-out preparation
Asepsis Announces the Grant of U.S. Patent 10,857,299
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-Dose® syringe provid
Asepsis Announces the U.S. Patent Grant No. 10,625,026
Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer rapid small volume subcutaneous or intra